About Illumina
Illumina is a company based in San Diego (United States) founded in 1993 by Mark Chee and Larry Bock.. Illumina has raised $28 million across 11 funding rounds from investors including State Farm, United States Department of Agriculture and HHS. The company has 29 employees as of March 31, 2024. Illumina has completed 16 acquisitions, including Advanced Liquid Logic, Affomix and Bluebee. Illumina operates in a competitive market with competitors including DNAnexus, Depixus, Genomics, Seven Bridges Genomics and Hexagon Bio, among others.
- Headquarter San Diego, United States
- Employees 29 as on 31 Mar, 2024
- Founders Mark Chee, Larry Bock
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Illumina India Biotechnology Private Limited
- Date of Incorporation 20 Jun, 2018
- Jurisdiction Sector -45, Haryana, India
-
Annual Revenue
$1.44 M (USD)316.12as on Mar 31, 2023
-
Net Profit
$70.34 K (USD)167as on Mar 31, 2023
-
EBITDA
$328.59 K (USD)835.6as on Mar 31, 2023
-
Total Equity Funding
$28 M (USD)
in 11 rounds
-
Latest Funding Round
-
Investors
State Farm
& 13 more
-
Employee Count
29
as on Mar 31, 2024
-
Investments & Acquisitions
Advanced Liquid Logic
& 15 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Illumina
Illumina is a publicly listed company on the NASDAQ with ticker symbol ILMN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Software Development Team
249 people
Senior Team
70 people
Leadership Team
67 people
Sales and Marketing
44 people
Staff Team
42 people
Product Management Team
36 people
Finance and Accounting
31 people
Data Analysis and Operations Team
25 people
Unlock access to complete
Funding Insights of Illumina
Illumina has successfully raised a total of $28M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Last Round
-
First Round
First Round
(10 Jan 2000)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - Illumina | Valuation |
investors |
|
| Aug, 2019 | Amount | Grant - Illumina | Valuation |
investors |
|
| Aug, 2014 | Amount | Grant - Illumina | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Illumina
Illumina has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include State Farm, United States Department of Agriculture and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Seed & early stage multiple stage focused corp VC firm funding companies in the US and Canada
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Illumina
Illumina has strategically engaged in corporate development activities, having acquired 16 companies. Notable acquisitions include Advanced Liquid Logic, Affomix and Bluebee. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Proprietary reagents for single-cell genetic analysis are developed.
|
2018 | ||||
|
Circulating tumor DNA is screened for early cancer detection.
|
2016 | ||||
|
Next-generation sequencing analysis and genomic data compression are provided.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Illumina
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Illumina Comparisons
Competitors of Illumina
Illumina operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Depixus, Genomics, Seven Bridges Genomics and Hexagon Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| domain | founded_year | HQ Location |
DNA sequencing technology is developed to detect genomic mutations.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Illumina
Frequently Asked Questions about Illumina
When was Illumina founded?
Illumina was founded in 1993 and raised its 1st funding round 7 years after it was founded.
Where is Illumina located?
Illumina is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Illumina a funded company?
Illumina is a funded company, having raised a total of $28M across 11 funding rounds to date. The company's 1st funding round was a Grant of $346.93K, raised on Jan 10, 2000.
How many employees does Illumina have?
As of Mar 31, 2024, the latest employee count at Illumina is 29.
What is the annual revenue of Illumina?
Annual revenue of Illumina is $1.44M as on Mar 31, 2023.
What does Illumina do?
Developer of technologies for analysis of genetic variation and function. The company provides laboratory instruments, kits, and reagents for research, drug development, and the development of molecular tests. The product categories include gene panel and array finder, microarray kits, clinical research, and IVD products.
Who are the top competitors of Illumina?
Illumina's top competitors include DNAnexus, Depixus and Ingenuity Systems.
Is Illumina publicly traded?
Yes, Illumina is publicly traded on NASDAQ under the ticker symbol ILMN.
How many acquisitions has Illumina made?
Illumina has made 16 acquisitions, including Advanced Liquid Logic, Affomix, and Bluebee.
Who are Illumina's investors?
Illumina has 14 investors. Key investors include State Farm, United States Department of Agriculture, HHS, Dow, and Chase.
What is Illumina's ticker symbol?
The ticker symbol of Illumina is ILMN on NASDAQ.